Gian Lifecare Ltd vs Invicta Diagnostic Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Gian Lifecare Ltd is ₹ 4.2 as of 23 Oct 15:30 . The P/E Ratio of Gian Lifecare Ltd changed from 9.8 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Invicta Diagnostic Ltd changed from 16.1 on March 2026 to 16.1 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Gian Lifecare Ltd changed from ₹ 42.97 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Invicta Diagnostic Ltd changed from ₹ 79.2 crore on March 2026 to ₹ 79.2 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of Gian Lifecare Ltd for the Dec '25 is ₹ 1.21 crore as compare to the Sep '25 revenue of ₹ 0.75 crore. This represent the growth of 61.33% The revenue of Invicta Diagnostic Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Gian Lifecare Ltd for the Dec '25 is ₹ 0.33 crore as compare to the Sep '25 ebitda of ₹ -0.32 crore. This represent the decline of -203% The ebitda of Invicta Diagnostic Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Gian Lifecare Ltd changed from ₹ 0.09 crore to ₹ 0.1 crore over 7 quarters. This represents a CAGR of 6.21% The net profit of Invicta Diagnostic Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Gian Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Invicta Diagnostic Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Gian Lifecare Ltd

Gian Life Care Limited was incorporated as a Public Limited Company and registered with the Registrar of Companies, Uttar Pradesh, Kanpur with the name & style 'Gian Life Care Limited' pursuant to a Certificate of Incorporation dated November 06, 2018.
Subsequently, Company acquired the entire business of M/s Gian Pathology & X-Ray, sole proprietorship concern of its Promoter Mr. Arun Kumar Gupta w.e.f.
March 01, 2019. Company is a fast growing professionally managed organization with an ultra-modem fully integrated, manufacturing facility dedicated to provide diagnostic services.
It established the organization in 2018.
Gian' is committed to Quality services that address the prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. The diagnostic center under the name of 'M/s.

About Invicta Diagnostic Ltd

Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name 'Invicta Diagnostic LLP' vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre.
Further, Invicta Diagnostic LLP converted into a Private Limited Company as 'Invicta Diagnostic Private Limited' dated December 01, 2023.
Subsequently, Company converted from a Private Limited to a Public Limited Company, and the name was changed to 'Invicta Diagnostic Limited' and a fresh Certificate of Incorporation dated July 02, 2024 was issued by the Central Processing Centre. Invicta Diagnostic Limited is an innovative diagnostic chain in Mumbai Metropolitan Region (MMR) offering comprehensive radiology and pathology solutions.
It offer a one-stop solution for pathology and radiology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers through a network, consisting of 8 diagnostic centres and 1 centralised laboratory across Mumbai Metropolitan Region in Maharashtra.

FAQs for the comparison of Gian Lifecare Ltd and Invicta Diagnostic Ltd

Which company has a larger market capitalization, Gian Lifecare Ltd or Invicta Diagnostic Ltd?

Market cap of Gian Lifecare Ltd is 4 Cr while Market cap of Invicta Diagnostic Ltd is 76 Cr

What are the key factors driving the stock performance of Gian Lifecare Ltd and Invicta Diagnostic Ltd?

The stock performance of Gian Lifecare Ltd and Invicta Diagnostic Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gian Lifecare Ltd and Invicta Diagnostic Ltd?

As of October 24, 2026, the Gian Lifecare Ltd stock price is INR ₹4.2. On the other hand, Invicta Diagnostic Ltd stock price is INR ₹60.5.

How do dividend payouts of Gian Lifecare Ltd and Invicta Diagnostic Ltd compare?

To compare the dividend payouts of Gian Lifecare Ltd and Invicta Diagnostic Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.